【结 构 式】 |
【分子编号】27709 【品名】methyl (2S)-2-amino-4-methylpentanoate 【CA登记号】 |
【 分 子 式 】C7H15NO2 【 分 子 量 】145.20164 【元素组成】C 57.9% H 10.41% N 9.65% O 22.04% |
合成路线1
该中间体在本合成路线中的序号:(VIII)Suzuki coupling of methyl 2-bromo-4-nitrobenzoate (I) with 1-naphthylboronic acid (II) provided naphthyl benzoate ester (III). The nitro group of (III) was then reduced by hydrogenation over Pd/C yielding aniline (IV). Diazotization of (IV), followed by reaction with KI gave aryl iodide (V), and subsequent halogen displacement by KCN in the presence of palladium catalyst afforded nitrile (VI). After basic hydrolysis of the methyl ester of (VI), the resulting carboxylic acid (VII) was coupled to L-leucine methyl ester (VIII) using EDC and HOBt to yield amide (IX). Reduction of the nitrile group of (IX) with NaBH4 and CoCl2 gave the corresponding amine, which was isolated as the tert-butyl carbamate (X) upon treatment with Boc2O.
【1】 Vasudevan, A.; et al.; Potent, highly selective, and non-thiol inhibitors of protein geranylgeranyltransferase-I. J Med Chem 1999, 42, 8, 1333. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 27702 | methyl 2-bromo-4-nitrobenzoate | C8H6BrNO4 | 详情 | 详情 | |
(II) | 27703 | 1-naphthylboronic acid | 13922-41-3 | C10H9BO2 | 详情 | 详情 |
(III) | 27704 | methyl 2-(1-naphthyl)-4-nitrobenzoate | C18H13NO4 | 详情 | 详情 | |
(IV) | 27705 | methyl 4-amino-2-(1-naphthyl)benzoate | C18H15NO2 | 详情 | 详情 | |
(V) | 27706 | methyl 4-iodo-2-(1-naphthyl)benzoate | C18H13IO2 | 详情 | 详情 | |
(VI) | 27707 | methyl 4-cyano-2-(1-naphthyl)benzoate | C19H13NO2 | 详情 | 详情 | |
(VII) | 27708 | 4-cyano-2-(1-naphthyl)benzoic acid | C18H11NO2 | 详情 | 详情 | |
(VIII) | 27709 | methyl (2S)-2-amino-4-methylpentanoate | C7H15NO2 | 详情 | 详情 | |
(IX) | 27710 | methyl (2S)-2-[[4-cyano-2-(1-naphthyl)benzoyl]amino]-4-methylpentanoate | C25H24N2O3 | 详情 | 详情 | |
(X) | 27711 | methyl (2S)-2-[[4-[[(tert-butoxycarbonyl)amino]methyl]-2-(1-naphthyl)benzoyl]amino]-4-methylpentanoate | C30H36N2O5 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(I)The intermediate N-(pyridin-3-ylmethoxycarbonyl)-L-leucine (V) has been obtained as follows: L-Leucine methyl ester (I) was converted into the isocyanate (II) by conventional methods, and the resulting compound was condensed with 3-pyridylmethanol (III) to yield the N-acylated leucine methyl ester (IV). Finally, this compound was hydrolyzed with LiOH to afford the desired intermediate N-(pyridin-3-ylmethoxycarbonyl)-L-leucine (V).
【1】 Ellman, J.A.; Lee, A.; Huang, L. ; Identification of potent and selective mechanism-based inhibitors of the cysteine protease cruzain using solid-phase parallel synthesis. J Med Chem 2002, 45, 3, 676. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 27709 | methyl (2S)-2-amino-4-methylpentanoate | C7H15NO2 | 详情 | 详情 | |
(II) | 54421 | methyl (2S)-2-isocyanato-4-methylpentanoate | C8H13NO3 | 详情 | 详情 | |
(III) | 15798 | 3-Pyridinemethanol; 3-pyridinylmethanol | 100-55-0 | C6H7NO | 详情 | 详情 |
(IV) | 54422 | methyl (2S)-4-methyl-2-{[(3-pyridinylmethoxy)carbonyl]amino}pentanoate | C14H20N2O4 | 详情 | 详情 | |
(V) | 54423 | (2S)-4-methyl-2-{[(3-pyridinylmethoxy)carbonyl]amino}pentanoic acid | C13H18N2O4 | 详情 | 详情 |